Poco X7 Pro, Poco X7 India launch on January 9. Poco X7 series is set to break cover in India on January 9, 2025, Poco has announced. There are two phones in the fray. These are the Poco X7 and ...

Poco X7 Pro should come with a 6.67 inch 1.5K OLED ... Both the phones are likely to run on Xiaomi's latest HyperOS 2.0 based on Android 15 and also feature an IP68 rating for dust and water ...

Poco was launched as a Xiaomi brand ... at an affordable price. Poco was separated into an independent brand by the Chinese electronics giant in 2020, before the launch of its second phone. Poco's ...

Poco is known for offering high-performance devices at competitive prices. Here are the top 10 ... supports 67W wired fast charging. The Poco X6 Pro 5G features a 6.67-inch 120Hz AMOLED display.

Poco X7 and Poco X7 Pro leaked renders Xiaomi has already launched Redmi phones as Poco devices in the past. The predecessor Poco X6 was identical to the Redmi Note 13 Pro, while the Poco X6 Pro ...

The Poco C75 5G is Xiaomi’s latest attempt to capture the budget 5G smartphone market. With a starting price of under Rs ...

The Poco X7 Pro 5G could sport a 6.67-inch CrystalRez 1.5K AMOLED screen. The vanilla Poco X7 could have a 6.67-inch 120Hz AMOLED 1.5K display with Corning Gorilla Glass Victus 2 protection and a ...

On Jan. 9, the Poco X7 Pro will make its debut alongside the Poco X7 in multiple markets, including India. The Flipkart page of the Pro variant has now been updated with some of its key specifications ...

The Poco M7 Pro 5G makes an impressive case for itself in the competitive budget smartphone market, claiming to deliver more value than its price tag suggests. With features like an OLED panel ...

The Xiaomi 14 CIVI has a 6.55-inch Quad Curved AMOLED display with a 120Hz refresh rate and a peak brightness of 3,000 nits. The phone is powered by the Snapdragon 8s Gen 3 SoC paired with up to ...

NEW YORK (Reuters) - Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...